Sep 2026
Abstract A012: Investigating the heterogeneity of different KRAS point mutations on DRP1 activation and its regulation of the TME in pancreatic cancer
This group identified that DRP1 loss in KRAS-mutant PDAC tumor cells alters mitochondrial shape and reduces glycolysis and cell proliferation in murine models and hypothesize that reliance on DRP1 activation in PDAC is KRAS-mutant-specific and shapes the TME to promote survival.
V. Remley, Varna Selvakumar, Nadiya Harris et al.
· Cancer Research · 0 citations